Target intelligence / Profile preview

Aldo-keto reductase family 1 member B10 pseudogene 2 (AKR1B10P2)

Target
AKR1B10P2
Molecular classification
Pseudogene
01

Overview

Aldo-keto reductase family 1 member B10 pseudogene 2 (AKR1B10P2) is a pseudogene, meaning it is a nonfunctional segment of DNA that closely resembles the protein-coding gene AKR1B10, but lacks the ability to produce a functional protein product. Pseudogenes typically arise via duplication or retrotransposition events and may lack key regulatory or coding sequences required for proper gene function. While most pseudogenes are regarded as nonfunctional, some can have regulatory roles, for example as sources of regulatory non-coding RNAs or as molecular sponges for microRNAs. The closely-related pseudogene AKR1B10P1 has been shown to have such a regulatory role in hepatocellular carcinoma, by acting as a ceRNA (competitive endogenous RNA) that can sponge miR-138 and thereby alter the expression of EMT-promoting genes; similar roles for AKR1B10P2 are not reported in the available literature. There are no drugs, biomarkers, or safety concerns directly associated with AKR1B10P2. Given that AKR1B10P2 is a pseudogene, it is not considered a therapeutic target and has no known direct protein product or drug interactions. Some confusion can arise as pseudogenes are occasionally annotated as functional genes, but in this case, AKR1B10P2 is definitively identified as a pseudogene by major gene databases and scientific literature. Note: Most of the literature discussing biological function and disease relevance refers to AKR1B10 or its other pseudogenes (e.g., AKR1B10P1), but not explicitly to AKR1B10P2 itself. Therefore, any putative function is speculative and not established for AKR1B10P2.

Other names
Aldo-keto reductase family 1, member B10 (aldose reductase) pseudogeneAKR1B10P2
02

Biological functions

Regulatory function as a non-coding RNA via ceRNA (competitive endogenous RNA) mechanismsDoes not have enzymatic activity or receptor function typically associated with therapeutic targets
03

Disease associations

Cancer (pseudogenes including the related AKR1B10P1 have regulatory roles in cancer, e.g., hepatocellular carcinoma; some pseudogenes can participate in regulatory RNA networks relevant for tumorigenesis)

Beyond the preview

Go deeper on Aldo-keto reductase family 1 member B10 pseudogene 2 (AKR1B10P2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aldo-keto reductase family 1 member B10 pseudogene 2 (AKR1B10P2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call